𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oxcarbazepine—Efficacy and Tolerability During Treatment of Alcohol Withdrawal: A Double-Blind, Randomized, Placebo-Controlled Multicenter Pilot Study

✍ Scribed by Dagmar Koethe; Antje Juelicher; Brit M. Nolden; Wolf-Dietrich Braunwarth; Joachim Klosterkötter; Günter Niklewski; Norbert Wodarz; Jan Klatt; Wilhelm Burtscheidt; Wolfgang Gaebel; F. Markus Leweke


Book ID
109123806
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
163 KB
Volume
31
Category
Article
ISSN
0145-6008

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Rifaximin for the treatment of active po
✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

Sulfasalazine in the treatment of juveni
✍ Marion A. J. van Rossum; Theo J. W. Fiselier; Marcel J. A. M. Franssen; Aeilko H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula

Gabapentin in the treatment of fibromyal
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin